Empowering Discovery,
Enhancing Knowledge

InLighta BioSciences, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded an NIH grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis.

Health Imaging recently reported InLighta’s development of a protein-based MRI contrast agent designed to target liver cancer biomarkers for earlier cancer detection.

Nature Reviews Gastroenterology and Hepatology recently published a review about InLighta’s collagen-targeted MRI contrast agent for liver fibrosis, which provides direct quantification of collagen deposition in preclinincal liver disease models.